NMRA peer analysis
Neumora Therapeutics (NMRA) against its competitors: price, today's move, 1-year return and market value side by side.
- NMRA's peers: ADCT (ADC Therapeutics), ALMS (Alumis), AUTL (Autolus Therapeutics), BCYC (Bicycle Therapeutics), FDMT (4D Molecular), FULC (Fulcrum Therapeutics), LXRX (Lexicon Pharmaceuticals), OMER (Omeros).
NMRA and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ADCT ADC Therapeutics | $1.28 | -1.54% | -68.16% | $180.05M |
| ALMS Alumis | $4.03 | -6.93% | -38.66% | $523.18M |
| AUTL Autolus Therapeutics | $0.92 | -6.08% | -27.56% | $245.03M |
| BCYC Bicycle Therapeutics | $2.90 | -4.92% | -53.60% | $202.98M |
| FDMT 4D Molecular | $10.23 | -4.57% | -5.28% | $740.49M |
| FULC Fulcrum Therapeutics | $3.68 | -0.81% | -68.03% | $281.09M |
| LXRX Lexicon Pharmaceuticals | $1.50 | -10.03% | 3.62% | $668.96M |
| OMER Omeros | $13.19 | -5.85% | 60.46% | $982.17M |
| PRTA Prothena | $8.20 | -2.38% | -17.92% | $421.07M |
| NMRA Neumora Therapeutics | $0.35 | -5.40% | -86.34% | $65.48M |